Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 6178 [2018-02827]

Download as PDF 6178 Federal Register / Vol. 83, No. 30 / Tuesday, February 13, 2018 / Notices Date: April 18, 2018. Time: 10:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–02825 Filed 2–12–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW) ACTION: Notice. The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the ACBCYW. The ACBCYW consists of 15 experts in fields associated with breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women, or in related disciplines with a specific focus on young women. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of breast health, breast cancer, disease prevention and risk reduction, survivorship (including metastatic breast cancer), hereditary breast and ovarian cancer (HBOC), or in related disciplines with a specific focus on young women. Persons with personal experience with early onset breast cancer are also eligible to apply. This includes, but may not be limited to breast cancer survivors <45 years of age and caregivers of said persons. Federal employees will not be considered for membership. Members may be invited to serve up to four-year sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 23:12 Feb 12, 2018 Jkt 244001 terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of ACBCYW objectives (http://www.cdc.gov/maso/ facm/facmacbcyw.html). DATES: Nominations for membership on the ACBCYW must be received no later than March 26, 2018. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Temeika L. Fairley, Ph.D. c/o ACBCYW Secretariat, Centers for Disease Control and Prevention, 3719 North Peachtree Road, Building 100 Chamblee, Georgia 30341, or emailed (recommended) to acbcyw@cdc.gov. FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop F–76, Atlanta, Georgia 30341; 770–488–4518; acbcyw@cdc.gov. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for ACBCYW membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in December 2018, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae, including complete contact information PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 (telephone numbers, mailing address, email address); D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–02827 Filed 2–12–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of closed meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) Funding Opportunity Announcement (FOA), PAR 16–098, Cooperative Research Agreements to the World Trade Center Health Program (U01). Dates: April 11, 2018 and April 12, 2018. Times: 8:00 a.m.–5:00 p.m., EDT, April 11, 2018 and 8:00 a.m.–2:00 p.m. EDT, April 12, 2017. E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Page 6178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02827]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Breast Cancer in Young Women (ACBCYW)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the ACBCYW. The ACBCYW consists 
of 15 experts in fields associated with breast cancer, disease 
prevention, early detection, diagnosis, public health, social 
marketing, genetic screening and counseling, treatment, rehabilitation, 
palliative care, and survivorship in young women, or in related 
disciplines with a specific focus on young women. Nominations are being 
sought for individuals who have expertise and qualifications necessary 
to contribute to the accomplishments of the committee's objectives. 
Nominees will be selected based on expertise in the fields of breast 
health, breast cancer, disease prevention and risk reduction, 
survivorship (including metastatic breast cancer), hereditary breast 
and ovarian cancer (HBOC), or in related disciplines with a specific 
focus on young women. Persons with personal experience with early onset 
breast cancer are also eligible to apply. This includes, but may not be 
limited to breast cancer survivors <45 years of age and caregivers of 
said persons. Federal employees will not be considered for membership. 
Members may be invited to serve up to four-year terms. Selection of 
members is based on candidates' qualifications to contribute to the 
accomplishment of ACBCYW objectives (http://www.cdc.gov/maso/facm/facmacbcyw.html).

DATES: Nominations for membership on the ACBCYW must be received no 
later than March 26, 2018. Packages received after this time will not 
be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to Temeika L. Fairley, 
Ph.D. c/o ACBCYW Secretariat, Centers for Disease Control and 
Prevention, 3719 North Peachtree Road, Building 100 Chamblee, Georgia 
30341, or emailed (recommended) to [email protected].

FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated 
Federal Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway NE, Mailstop F-76, Atlanta, 
Georgia 30341; 770-488-4518; [email protected].

SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human 
Services policy stipulates that committee membership be balanced in 
terms of points of view represented, and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens, and cannot be full-time employees of 
the U.S. Government. Current participation on federal workgroups or 
prior experience serving on a federal advisory committee does not 
disqualify a candidate; however, HHS policy is to avoid excessive 
individual service on advisory committees and multiple committee 
memberships. Committee members are Special Government Employees, 
requiring the filing of financial disclosure reports at the beginning 
and annually during their terms. CDC reviews potential candidates for 
ACBCYW membership each year, and provides a slate of nominees for 
consideration to the Secretary of HHS for final selection. HHS notifies 
selected candidates of their appointment near the start of the term in 
December 2018, or as soon as the HHS selection process is completed. 
Note that the need for different expertise varies from year to year and 
a candidate who is not selected in one year may be reconsidered in a 
subsequent year.
    Nominees must be U.S. citizens, and cannot be full-time employees 
of the U.S. Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address);
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-02827 Filed 2-12-18; 8:45 am]
 BILLING CODE 4163-18-P